Skip to main content
. 2015 Jul;5(7):a017277. doi: 10.1101/cshperspect.a017277

Figure 3.

Figure 3.

Distribution of mutation in mitochondrial DNA or OPA1 in a cohort of primary optic atrophy patients. Mutations in mitochondrial DNA or OPA1 are presented as a fraction of 64 patients evaluated through the genetic testing service at the Massachusetts Eye and Ear Infirmary. Fifty-six percent of patients with primary optic atrophy do not have a mutation in mitochondrial DNA, OPA1, or OPA3.